Literature DB >> 11160688

Role of cyclin D3 in the biology of herpes simplex virus 1 ICPO.

C Van Sant1, P Lopez, S J Advani, B Roizman.   

Abstract

Earlier reports from this laboratory have shown that the promiscuous transactivator infected-cell protein 0 (ICP0) binds and stabilizes cyclin D3, that the binding site maps to aspartic acid 199 (D199), and that replacement of D199 with alanine abolishes binding and reduces the capacity of the mutant virus to replicate in quiescent cells or to cause mortality in mice infected by a peripheral site. The objective of this report was to investigate the role of cyclin D3 in the biology of ICP0. We report the following results. (i) Wild-type ICP0 activates cyclin D-dependent kinase 4 (cdk4) and stabilizes cyclin D1 although ICP0 does not interact with this cyclin. (ii) The D199A mutant virus (R7914) does not activate cdk4 or stabilize cyclin D1, and neither the wild-type nor the mutant virus activates cdk2. (iii) Early in infection of human embryonic lung (HEL) fibroblasts both wild-type and D199A mutant ICP0s colocalize with PML, and in these cells the ND10 nuclear structures are dispersed. Whereas wild-type ICP0 is transported to the cytoplasm between 3 and 9 h. after infection, ICPO containing the D199A substitution remains quantitatively in the nucleus. (iv) To examine the interaction of ICP0 with cyclin D3, we used a previously described mutant carrying a wild-type ICP0 but expressing cyclin D3 (R7801) and in addition constructed a virus (R7916) that was identical except that it carried the D199A-substituted ICP0. Early in infection with R7801, ICP0 colocalized with cyclin D3 in structures similar to those containing PML. At 3 h after infection, ICP0 was translocated to the cytoplasm whereas cyclin D3 remained in the nucleus. The translocation of ICP0 to the cytoplasm was accelerated in cells expressing cyclin D3 compared with that of ICP0 expressed by wild-type virus. In contrast, ICP0 carrying the D199A substitution remained in the nucleus and did not colocalize with cyclin D3. These studies suggest the following conclusions. (i) ICP0 brings to the vicinity of ND10 cyclin D3 and, in consequence, an activated cdk4. The metabolic events occurring at or near that structure and involving cyclin D3 cause the translocation of ICP0 to the cytoplasm. (ii) In the absence of the cyclin D3 binding site in ICP0, cyclin D3 is not brought to ND10, cyclin D is not stabilized, and the function responsible for the translocation of ICP0 is not expressed, and in quiescent HEL fibroblasts the yields of virus are reduced.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160688      PMCID: PMC115135          DOI: 10.1128/JVI.75.4.1888-1898.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110.

Authors:  R D Everett; W C Earnshaw; J Findlay; P Lomonte
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3.

Authors:  Y Kawaguchi; C Van Sant; B Roizman
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms.

Authors:  R D Everett; P Freemont; H Saitoh; M Dasso; A Orr; M Kathoria; J Parkinson
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 4.  SCF and APC: the Yin and Yang of cell cycle regulated proteolysis.

Authors:  J M Peters
Journal:  Curr Opin Cell Biol       Date:  1998-12       Impact factor: 8.382

5.  Eukaryotic elongation factor 1delta is hyperphosphorylated by the protein kinase encoded by the U(L)13 gene of herpes simplex virus 1.

Authors:  Y Kawaguchi; C Van Sant; B Roizman
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

Authors:  M Li; H Lee; D W Yoon; J C Albrecht; B Fleckenstein; F Neipel; J U Jung
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein.

Authors:  R D Everett; M Meredith; A Orr; A Cross; M Kathoria; J Parkinson
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

8.  The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0.

Authors:  W O Ogle; T I Ng; K L Carter; B Roizman
Journal:  Virology       Date:  1997-09-01       Impact factor: 3.616

9.  Cellular elongation factor 1delta is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses.

Authors:  Y Kawaguchi; T Matsumura; B Roizman; K Hirai
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

10.  Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.

Authors:  Z K Yu; J L Gervais; H Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

View more
  33 in total

1.  Requirements for the nuclear-cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus 1.

Authors:  P Lopez; C Van Sant; B Roizman
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Posttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localize.

Authors:  S J Advani; R Hagglund; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  The U(S)3 protein kinase blocks apoptosis induced by the d120 mutant of herpes simplex virus 1 at a premitochondrial stage.

Authors:  J Munger; A V Chee; B Roizman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis.

Authors:  Luca Benetti; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 5.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Interwoven roles of cyclin D3 and cdk4 recruited by ICP0 and ICP4 in the expression of herpes simplex virus genes.

Authors:  Maria Kalamvoki; Bernard Roizman
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

7.  Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle.

Authors:  Kevin Maringer; Gillian Elliott
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

8.  The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.

Authors:  C Van Sant; R Hagglund; P Lopez; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

9.  The herpes simplex virus type 1 BgKL variant, unlike the BgOL variant, shows a higher association with orolabial infection than with infections at other sites, supporting the variant-dispersion-replacement hypothesis.

Authors:  Shigeru Ozawa; Hiroyuki Eda; Yasuyuki Ishii; Fumihiko Ban; Toshiyuki Funabashi; Seiichiro Hata; Kozaburo Hayashi; Hiroki Iga; Takao Ikushima; Hiroaki Ishiko; Tomoo Itagaki; Rinji Kawana; Shunsaku Kobayashi; Takeo Ogino; Tsuyoshi Sekizawa; Yoshikazu Shimomura; Hiroshi Shiota; Ryoichi Mori; Takashi Nakakita; Yoshio Numazaki; Yoshikatsu Ozaki; Shigeru Yamamoto; Kamesaburo Yoshino; Kazuo Yanagi
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

10.  Herpes simplex virus type 1 regulatory protein ICP0 does not protect cyclins D1 and D3 from degradation during infection.

Authors:  Roger D Everett
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.